Unique ID issued by UMIN | UMIN000049315 |
---|---|
Receipt number | R000056165 |
Scientific Title | Effect of encouraging people with non-communicable diseases to receive medical consultation based on medical data |
Date of disclosure of the study information | 2022/11/01 |
Last modified on | 2024/04/26 09:44:37 |
Effect of encouraging people with non-communicable diseases to receive medical consultation based on medical data
Effect of encouraging people with non-communicable diseases to receive medical consultation
Effect of encouraging people with non-communicable diseases to receive medical consultation based on medical data
Effect of encouraging people with non-communicable diseases to receive medical consultation
Japan |
hypertension, dyslipidemia, diabetes mellitus
Medicine in general | Adult |
Others
NO
To examine the effect of customized information on the behavior and disease management status of individuals with non-communicable diseases who need medical consultations
Efficacy
Confirmatory
Proportion of patients who receive treatment and retained treatment
Disease management status for non-communicable diseases
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Central registration
2
Prevention
Behavior,custom |
Intervention group
Clustering of factors related to medical consultation behavior based on medical data, and sending of medical consultation notifications appropriate to the appeal points according to the characteristics of the clusters
Sending regular medical consultation notifications
20 | years-old | <= |
Not applicable |
Male and Female
Insured persons in the Health Insurance Association
1. Persons who meet any of the following criteria based on the results of the medical checkup
- Blood pressure: Systolic blood pressure 160 mmHg or higher and/or diastolic blood pressure 100 mmHg or higher
- Lipid: Low-Density Lipoprotein (LDL) cholesterol level 180 mg/dL or higher and/or High-Density Lipoprotein (HDL) cholesterol level 30 mg/dL or lower and/or triglycerides 500 mg/dL or higher
- Blood glucose: Fasting blood glucose 140 mg/dL or higher and/or Hemoglobin A1c (HbA1c) 7.0% or higher
2. Those who have no medical history of the target disease
Those who refused to participate in the study
300
1st name | Masashi |
Middle name | |
Last name | Kanai |
Kanazawa University
Institute of Transdisciplinary Sciences for Innovation
920-1192
Kakuma-machi, Kanazawa, Ishikawa
076-234-6333
kanaimasa07@staff.kanazawa-u.ac.jp
1st name | Kento |
Middle name | |
Last name | Takeyama |
PREVENT inc.
Department of Business Planning
461-0004
1-26-12, Aoi, Higashi-ku, Nagoya, Aichi
052-715-7955
business_planning@prevent.co.jp
Kanazawa University
Ministry of Health, Labour and Welfare
Japanese Governmental office
PREVENT inc., Health Insurance Association for Suzuyo
Kanazawa University
Kakuma-machi, Kanazawa, Ishikawa
076-264-5920
yugosomu@adm.kanazawa-u.ac.jp
NO
鈴与健康保険組合
2022 | Year | 11 | Month | 01 | Day |
Unpublished
No longer recruiting
2022 | Year | 09 | Month | 15 | Day |
2022 | Year | 09 | Month | 15 | Day |
2022 | Year | 11 | Month | 01 | Day |
2024 | Year | 03 | Month | 31 | Day |
2024 | Year | 07 | Month | 31 | Day |
2022 | Year | 10 | Month | 25 | Day |
2024 | Year | 04 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056165